openPR Logo
Press release

Hormone Replacement Therapy Market Explore Future Growth 2026 By Global Key Players Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical, and Eli Lilly and Company

10-29-2018 03:48 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Hormone Replacement Therapy Market

Global Hormone Replacement Therapy Market

Hormone replacement therapy is used when the human body is not able to produce enough hormones. It is used for the treatment for menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency conditions.

Rising incidences of hormonal imbalance disorders and increasing geriatric and neonatal population suffering from these diseases are expected to boost the growth of the market. According to the statistics provided by the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause on a daily basis in the U.S.

Download PDF Brochure of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/2079

Market Dynamics:

Increasing number of people suffering from hypogonadism and rising adoption of testosterone products in various economies is expected to propel the overall growth of the market. According to the data published in the European Association of Urology Journal: 2017, testosterone prescription trends in the U.S. exhibited an increase between 1.8- and 4-fold over the last two decades (1997 - 2017). Moreover, from 2000 to 2011, there was a 4.3-fold increase in testosterone testing when compared to a 3.7-fold increase in prescriptions.

Rising number of generic versions of hormone replacement therapies by various manufacturers will drive the growth of the market in terms of volume and value. For instance, Teva Pharmaceutical Industries Ltd. launched the generic Axiron1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. on August 18, 2017, to treat adult males who have low or no testosterone due to certain medical conditions. This solution was supplied in a metered dose pump with an underarm applicator.

Key features of the study:

• This report provides in-depth analysis of the hormone replacement therapy market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains the attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global hormone replacement therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company
• Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global hormone replacement therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for hormone replacement therapy market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Hormone Replacement Therapy Market, By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy

Global Hormone Replacement Therapy Market, By Route of Administration:
Oral
Parenteral
Others

Global Hormone Replacement Therapy Market, By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others

Else place an Inquire before Purchase “Global Hormone Replacement Therapy Market Size, Status and Forecast 2026 @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2079

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hormone Replacement Therapy Market Explore Future Growth 2026 By Global Key Players Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical, and Eli Lilly and Company here

News-ID: 1336555 • Views:

More Releases from Coherent Market Insights

Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent …
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Current
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti …
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample

All 5 Releases


More Releases for Therapy

Visual Arts Therapy Market Future Business Opportunities 2024-2031 | American Ar …
A recent report titled "Visual Arts Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Visual
Hair Transplant Market by Therapy (Platelet-Rich Plasma Therapy (PRP), Stem Cell …
Hair transplant refers to the market for surgical procedures aimed at restoring hair growth in individuals experiencing hair loss or baldness. These procedures involve the transplantation of hair follicles from one part of the body to the balding or thinning areas. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-hair-transplant-market The expansion of biotechnology sector across the globe, acts as one of the major factors driving the growth of global hair transplant market. The increase in the
Melanoma Therapeutics Market By Chemotherapy, Biologic therapy, Targeted therapy …
Melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,